Moderna (MRNA)
NASDAQ:MRNA
Holding MRNA?
Track your performance easily

Moderna (MRNA) Income Statement

16,106 Followers

Moderna Income Statement

Last quarter (Q3 2024), Moderna's total revenue was $1.86B, an increase of 4.20% from the same quarter last year. In Q3, Moderna's net income was $13.00M. See Moderna’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.08B$ 6.75B$ 18.88B$ 17.74B$ 274.00M$ 60.21M
Cost of Revenue
$ 1.65B$ 4.69B$ 5.42B$ 2.62B$ 8.00M-
Gross Profit
$ 3.43B$ 2.06B$ 13.46B$ 15.12B$ 266.00M$ 60.21M
Operating Expense
$ 6.03B$ 6.30B$ 4.04B$ 2.56B$ 1.56B$ 605.93M
Operating Income
$ -2.69B$ -4.24B$ 9.42B$ 13.30B$ -763.00M$ -545.72M
Net Non Operating Interest Income Expense
$ -367.00M$ -383.00M$ -171.00M$ 18.00M$ 25.00M$ 38.53M
Other Income Expense
$ -113.00M$ -86.00M$ -16.00M$ 29.00M$ 6.00M$ 7.53M
Pretax Income
$ -2.35B$ -3.94B$ 9.57B$ 13.29B$ -744.00M$ -514.72M
Tax Provision
$ -129.00M$ 772.00M$ 1.21B$ 1.08B$ 3.00M$ -695.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -2.22B$ -4.71B$ 8.36B$ 12.20B$ -747.00M$ -514.02M
Basic EPS
$ -5.75$ -12.33$ 21.26$ 30.31$ -1.96$ -1.55
Diluted EPS
$ -5.74$ -12.33$ 20.12$ 28.29$ -1.96$ -1.55
Basic Average Shares
$ 1.53B$ 382.00M$ 394.00M$ 403.00M$ 381.33M$ 330.80M
Diluted Average Shares
$ 1.53B$ 382.00M$ 416.00M$ 431.00M-$ 330.80M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 7.77B$ 10.99B$ 9.46B$ 5.17B$ 1.57B$ 605.93M
Net Income From Continuing And Discontinued Operation
$ -2.22B$ -4.71B$ 8.36B$ 12.20B$ -747.00M$ -514.02M
Normalized Income
$ -1.32B$ -3.11B--$ -587.76M$ -515.41M
Interest Expense
------
EBIT
$ -2.35B$ -3.90B$ 9.60B$ 13.30B$ -763.00M$ -508.16M
EBITDA
$ -2.02B$ -3.28B$ 9.95B$ 13.53B$ -732.00M$ -477.16M
Currency in USD

Moderna Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis